Ambalal Sarabhai zooms over 18%

Ambalal Sarabhai today morning opened 18% higher at Rs.33 and went on to hit a new 52-week high at Rs.33.40, with volumes going up over 4 times.

India is witnessing an outbreak of Mucormycosis, the black fungus infection in post-Covid patients. The most recommended treatment for this infection is Amphotericin B injection.

The company’s subsidiary, Synbiotics is the only manufacturer of the Active Pharmaceutical Ingredient (API) Amphotericin B in India and looking at the current outbreak of this infection and expected requirement, Synbiotics has ramped up the manufacturing capacity to meet the requirement.

Synbiotics has the State of the Art fermentation plant for the manufacturing of the API Amphotericin B.